Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cantourage Group's full cannabis extracts are pharmaceutical-grade botanical extracts intended for use as formulation starting materials in pharmacies. Based in Berlin, Cantourage processes raw cannabis materials from global licensed producers under EU Good Manufacturing Practice (GMP) standards in Germany. These extracts are designed to be used by pharmacists to compound individualized cannabis-based medicinal preparations. Unlike finished drug products, these extracts do not have specific clinical trial phases or single targeted indications but are part of a broader therapeutic portfolio including flowers, dronabinol, and CBD. As full extracts, they contain a complete profile of cannabinoids and terpenes found in the cannabis plant, rather than isolated compounds.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on full cannabis extract (Cantourage Group).